48
Views
3
CrossRef citations to date
0
Altmetric
Articles

Determination and mathematical modelling of budesonide solubility in N-methyl-2-pyrrolidone + water mixtures from T = 293.2 to 313.2 K

, , ORCID Icon & ORCID Icon
Pages 834-842 | Received 27 Sep 2017, Accepted 19 Nov 2017, Published online: 27 Nov 2017

References

  • Johansson SA, Andersson KE, Brattsand R, et al. Topical and systemic glucocorticoid potencies of budesonide and beclomethasone dipropionate in man. Eur J Clin Pharmacol. 1982;22:523–529. Available from https://doi.org/10.1007/BF00609625
  • Juniper EF, Kline PA, Vanzieleghem MA, et al. Effect of long-term treatment with an inhaled corticosteroid (budesonide) on airway hyperresponsiveness and clinical asthma in nonsteroid-dependent asthmatics. Am Rev Respir Dis. 1990;142:832–836.
  • Spencer CM, McTavish D. Budesonide. Drugs. 1995;50:854–872.
  • Donnelly R, Seale JP. Clinical pharmacokinetics of inhaled budesonide. Clin Pharmacokinet. 2001;40:427–440.
  • Dalby C, Polanowski T, Larsson T, et al. The bioavailability and airway clearance of the steroid component of budesonide/formoterol and salmeterol/fluticasone after inhaled administration in patients with COPD and healthy subjects: a randomized controlled trial. Respir Res. 2009;10:104–115.
  • Di L, Fish PV, Mano T. Bridging solubility between drug discovery and development. Drug Discov Today. 2012;17:486–495.
  • Zhou L, Yang L, Tilton S, et al. Development of a high throughput equilibrium solubility assay using miniaturized shake‐flask method in early drug discovery. Drug Discov Today. 2007;96:3052–3071.
  • Alsenz J, Kansy M. High throughput solubility measurement in drug discovery and development. Adv Drug Delivery Rev. 2007;59:546–567.
  • Mota FL, Carneiro AP, Queimada AJ, et al. Temperature and solvent effects in the solubility of some pharmaceutical compounds: measurements and modeling. Eur J Pharm Sci. 2009;37:499–507.
  • Ali HSM, York P, Blagden N, et al. Solubility of budesonide, hydrocortisone, and prednisolone in ethanol + water mixtures at 298.2 K. J Chem Eng Data. 2009;55:578–582.
  • Strickley RG. Solubilizing excipients in oral and injectable formulations. Pharm Res. 2004;21:201–230.
  • Jouyban A, Fakhree MAA, Shayanfar A. Review of pharmaceutical applications of N-methyl-2-pyrrolidone. J Pharm Pharm Sci. 2010;13:524–535.
  • Lee PJ, Langer R, Shastri VP. Role of N‐methyl pyrrolidone in the enhancement of aqueous phase transdermal transport. J Pharm Sci. 2005;94:912–917.
  • Uch AS, Hesse U, Dressman JB. Use of 1-methyl-pyrrolidone as a solubilizing agent for determining the uptake of poorly soluble drugs. Pharm Res. 1999;16:968–971.
  • Ishihara T, Goto M, Kanazawa H, et al. Efficient entrapment of poorly water‐soluble pharmaceuticals in hybrid nanoparticles. J Pharm Sci. 2009;98:2357–2363.
  • Koizumi A, Fujii M, Kondoh M, et al. Effect of N-methyl-2-pyrrolidone on skin permeation of estradiol. Eur J Pharm Biopharm. 2004;57:473–478.
  • Jouyban A. Review of the cosolvency models for predicting solubility of drugs in water-cosolvent mixtures. J Pharm Pharm Sci. 2008;11:32−58.
  • Jouyban-Gharamaleki A, Valaee L, Barzegar-Jalali M, et al. Comparison of various cosolvency models for calculating solute solubility in water–cosolvent mixtures. Int J Pharm. 1999;177:93–101.
  • Jouyban A, Fakhree MAA. Toxicity and drug testing. In: Acree Jr WE, editor. Intech co. Chap. 9. New York (NY): Intech co.; 2012.
  • Delgado DR, Rodríguez GA, Martínez F. Thermodynamic study of the solubility of sulfapyridine in some ethanol + water mixtures. J Mol Liq. 2013;177:156–161.
  • Vahdati S, Shayanfar A, Hanaee J, et al. Solubility of carvedilol in ethanol + propylene glycol mixtures at various temperatures. Ind Eng Chem Res. 2013;52:16630–16636.
  • Jouyban-Gharamaleki A, Acree WE Jr. Comparison of models for describing multiple peaks in solubility profile. Int J Pharm. 1998;167:177–182.
  • Jouyban A, Khoubnasabjafari M, Chan HK, et al. Mathematical representation of solubility of amino acids in binary aqueous-organic solvent mixtures at various temperatures using Jouyban-Acree model. Pharmazie. 2006;61:789–792.
  • Jouyban A, Acree WE Jr. In silico prediction of drug solubility in water-ethanol mixtures using Jouyban-Acree model. J Pharm Pharm Sci. 2006;9:262–269.
  • Jouyban-Gharamaleki A. The modified Wilson model and predicting drug solubility in water-cosolvent mixtures. Chem Pharm Bull. 1998;46:1058–1061.
  • Shayanfar A, Fakhree MAA, Acree WE Jr, et al. Solubility of lamotrigine, diazepam, and clonazepam in ethanol + water mixtures at 298.15 K. J Chem Eng Data. 2008;54:1107–1109.
  • Soltanpour S, Jouyban A. Solubility of acetaminophen and ibuprofen in polyethylene glycol 600, N-methyl pyrrolidone and water mixtures. J Solution Chem. 2011;40:2032–2045.
  • Eghrary SH, Zarghami R, Martinez F, et al. Solubility of 2-butyl-3-benzofuranyl 4-(2-(diethylamino) ethoxy)-3, 5-diiodophenyl ketone hydrochloride (amiodarone HCl) in ethanol + water and N-methyl-2-pyrrolidone + water mixtures at various temperatures. J Chem Eng Data. 2012;57:1544–1550.
  • Soltanpour S, Jafari B, Barzegar-Jalali M, et al. Solubility of glibenclamide in the aqueous mixtures of polyethylene glycol 400, propylene glycol and N-methyl-pyrrolidone at 298.2 K. J Drug Deliv Sci Technol. 2014;24:111–115.
  • Sanghvi R, Narazaki R, Machatha SG, et al. Solubility improvement of drugs using N-methyl pyrrolidone. Aaps Pharmscitech. 2008;9:366–376.
  • Sajedi-Amin S, Barzegar-Jalali M, Fathi-Azarbayjani A, et al. Solubilization of bosentan using ethanol as a pharmaceutical cosolvent. J Mol Liq. 2017;232:152–158.
  • Bustamante P, Romero S, Peña A, et al. Enthalpy–entropy compensation for the solubility of drugs in solvent mixtures: paracetamol, acetanilide, and nalidixic acid in dioxane–water. J Pharm Sci. 1998;87:1590–1596.
  • Delgado DR, Martínez F. Solubility and solution thermodynamics of some sulfonamides in 1-propanol + water mixtures. J Solution Chem. 2014;43:836–852.
  • Jouyban A, Soltanpour S, Soltani S, et al. Solubility prediction of drugs in water-cosolvent mixtures using Abraham solvation parameters. J Pharm Pharm Sci. 2007;10:294–308.
  • Jouyban A. Handbook of solubility data for pharmaceuticals. Boca Raton (FL): CRC Press; 2010.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.